CGTX
CGTX
NASDAQ · Pharmaceuticals

Cognition Therapeutics Inc

$1.45
+0.03 (+2.11%)
As of Jun 21, 10:41 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +2,035.2% upside
Low Target $22.83
Average Target $30.96
High Target $36.58
Current Price $1.45
Current
$1.45
Target
$30.96
$22.83 $30.96 avg $36.58
Scenario Analysis
Bear Case
$22.83
1,474.5%
Low target
Base Case
$30.96
+2,035.2%
Avg target
Bull Case
$36.58
+2,422.8%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$3.83
-62.1% from high
52-Week Low
$0.25
+480.0% from low
Target vs 52W High
$30.96
+708.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%